Pseudomonas aeruginosa-mediated cardiac dysfunction is driven by extracellular vesicles released during infection

Naresh Kumar1, Sameer Salam Matoo1, Shridhar Sanghvi2

  • 1Department of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, USA.

Mbio
|January 15, 2026
PubMed

Insights

Pseudomonas aeruginosa pneumonia causes cardiac dysfunction via bacterial outer membrane vesicles (OMVs). These OMVs, found in exosomes from infected cells, damage heart cells and lead to severe cardiovascular complications and mortality.

Area of Science:

  • Microbiology
  • Cardiology
  • Immunology

Background:

  • Pseudomonas aeruginosa is a major cause of healthcare-associated pneumonia with high mortality.
  • Pneumonia, particularly from P. aeruginosa, is linked to cardiovascular diseases (CVD), yet mechanisms are unclear.
  • P. aeruginosa lung infection causes cardiac dysfunction and electrical disturbances.

Purpose of the Study:

  • To elucidate the mechanisms of P. aeruginosa-induced cardiac dysfunction.
  • To identify mediators responsible for cardiotoxicity during P. aeruginosa infection.

Main Methods:

  • In vitro studies using human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) exposed to conditioned media from infected macrophages.
  • In vivo studies involving systemic administration of bacterial outer membrane vesicles (OMVs) in mice.
  • Liquid chromatography-tandem mass spectrometry (LC-MS/MS) to identify proteins within vesicles.

Main Results:

  • Conditioned media from P. aeruginosa-infected macrophages caused contractile dysfunction in hiPSC-CMs.
  • Exosomes from infected macrophages and P. aeruginosa OMVs were identified as key mediators.
  • Bacterial proteins, including toxins, within OMVs and exosomes were responsible for cardiotoxicity.
  • Systemic OMV administration in mice induced severe cardiac dysfunction.

Conclusions:

  • P. aeruginosa infection releases bacterial OMVs into circulation, mediating cardiac dysfunction.
  • Host-derived exosomes enriched with bacterial OMVs contribute to systemic inflammation and cardiac impairment.
  • Bacterial OMVs are critical effectors in P. aeruginosa-induced cardiovascular complications.